Comparative Effectiveness of Upadacitinib and Tofacitinib in Ulcerative Colitis: A U.S. Propensity-Matched Cohort Study.

Gursimran S KochharHimsikhar KhataniarVipul JairathFrancis A Farraye Aakash Desai

Published in: The American journal of gastroenterology (2024)

This study utilizing real-world data showed that upadacitinib was associated with improved disease-specific outcomes at 12 months compared to tofacitinib in patients with UC.

Keyphrases

ulcerative colitis
rheumatoid arthritis
electronic health record
big data
type diabetes
machine learning
metabolic syndrome
adipose tissue
data analysis
glycemic control